Skip to main content
Premium Trial:

Request an Annual Quote

NanoTherics Lands Funding from English Economic Development Agency

NEW YORK (GenomeWeb News) - NanoTherics said today that it has received a grant from Advantage West Midlands that it will use to advance its gene transfection technologies.
The Staffordshire, UK-based company was founded in 2007 and is based on technology developed at Keele University and the University of Florida. The company’s technology uses nanoparticles and magnetic fields in the delivery of DNA and other molecules into living cells, which could be used in gene therapy programs.
AWM is one of nine regional development agencies in England and it aims to fund programs creating jobs in the West Midlands.
The company plans to launch the magnefect-nano, a “flexible device which provides up to 1,000-fold better transfection efficiency than cationic lipid agents for short transfection times,” NanoTherics CEO Linda Cammish said in a statement.
NanoTherics did not disclose the amount of the grant from AWM.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.